ME
Medicamen Biotech Limited
MEDICAMEQ.NS · NSE
₹304.60 +1.25% (+₹3.75)
1M -5.45%
Market Cap ₹4.11B
P/E Ratio 37.95x
Div. Yield 0.33%
ROE 4.17%
Bulios Fair Price
₹207.5
31.9% downside
Current Price
₹304.6
Undervalued Fair Value Overvalued
According to Bulios Fair Price, MEDICAMEQ.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Moderate
4/9Valuation
40 /100
Fair P/E 37.95x
EV/EBITDA 19.97x
P/S 2.03x
Growth
48 /100
Stable EPS growth 22.89%
Rev. growth 12.08%
Book val. growth 13.26%
Profitability
26 /100
Weak Gross margin 29.28%
Net margin 5.34%
Op. margin 5.97%
Quality
22 /100
Poor ROIC 3.00%
ROE 4.17%
ROA 2.91%
Debt
88 /100
Low Debt/Equity 0.17x
Current ratio 2.54x
Int. coverage 4.48x
Stability
86 /100
Stable Beta 0.62x
Rev. volatility 19.81%
EPS volatility 16.23%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about MEDICAMEQ.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Rajesh Madan Pharma
Employees
405
Headquarters
New Delhi